Following her related presentation at CHEST 2020, Terri Weaver (University of Illinois Chicago, Chicago, IL, USA) took the time to speak with us about the long term effects of solriamfetol on excessive daytime sleepiness and functional outcomes in participants with obstructive sleep apnea.
1. What is known about the long and short term efficacy of solriamfetol in the treatment of obstructive sleep apnea? (0:05)
2. Could you give us an overview of the aims and design of the study you are presenting? (1:00)
3.What were the major findings of this study? (1:47)
4.Were there any side effects reported in the study? (3:55)
5.What are the implications of these findings for clinical practice? (4:41)
6.Which patients are most likely to benefit from solriamfetol and in whom is it contraindicated? (6:15)
Disclosures: Terri Weaver has received royalties for the use of the FOSQ from Philips Respironics and has acted as a speaker/consultant/advisor for ResMed, ResMed Germany, Merck Co, Inc., Nyxoah, Jazz Pharmaceuticals, Cook Medical, RWS, Verily Life Sciences, Stratevi, WCG MedAvante Prophase, Evidation Health, Inc. and Bayer AG.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the CHEST 2020 Annual Meeting (Virtual).
Share this Video
Related Videos In Sleep Related Breathing Disorders
Margaret Pisani, CHEST 2022: Highlights and networking opportunities
CHEST 2022 took place between October 16-19 in Nashville, TN, we interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) around her personal congress highlights and the networking opportunities which were available on site. Questions What CHEST presentations had the greatest impact this year and what were your personal […]
John Harsh, CHEST 2022: Long term safety of FT218 in the treatment of narcolepsy
Once-nightly sodium oxybate (FT218) is currently being investigated in the open label phase 3 study RESTORE (NCT04451668) for the treatment of narcolepsy. We caught up with Prof. John Harsh (University of Colorado Boulder, Boulder, CO, USA) to discuss the aims, design, inclusion criteria and interim findings of the RESTORE study. The abstract ‘LONG-TERM SAFETY OF […]
Joerg Steier, ATS 2022: the Delphi Consensus Statements on Excessive Daytime Sleepiness in Obstructive Sleep Apnea
It was a pleasure to talk with Professor Joerg Steier (King’s College London, London, UK) around the development of the Delphi Consensus Statements on the diagnosis and management of excessive daytime sleepiness in obstructive sleep apnea and how these statements will help identify and address the unmet needs. The abstract ‘Development of Delphi Consensus Statements […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!